Session Datesort descending
Peds Hem/Onc Independent Study 2024: January: Measuring Burnout in Pediatric Oncology Staff: Should We Be Using the Maslach Burnout Inventory? 01/01/2024 - 12:00am CST to 01/31/2024 - 11:45pm CST
Peds Hem/Onc Independent Study 2024: February: Experiences of Parenting a Child Receiving Dexamethasone During Maintenance Chemotherapy for ALL 02/01/2024 - 12:00am CST to 02/29/2024 - 11:45pm CST
Peds Hem/Onc Independent Study 2024: March: Oncology Clinicians’ Perspectives on Online Patient Portal Use in Pediatric and Adolescent Cancer 03/01/2024 - 12:00am CST to 03/31/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: April: We Are Done! Now What? Exploring End of Treatment Needs of Childhood Cancer Survivors and Their Parents 04/01/2024 - 12:00am CDT to 04/30/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: May: Infertility and Identity: A Closer Look Into Experiences of Emerging Young Adult Childhood Cancer Survivors 05/01/2024 - 12:00am CDT to 05/31/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: June: Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL 06/01/2024 - 12:00am CDT to 06/30/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: July: Experiences and Preferences of Truth-telling in Families of Children with Cancer: A Phenomenological Study 07/01/2024 - 12:00am CDT to 07/31/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: August: Guidelines for Outpatient Administration of Naxitamab: Experience from Atrium Health Levine Children's Hospital 08/01/2024 - 12:00am CDT to 08/31/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: September: Virtual Reality for Pediatric Oncology Port-A-Cath Access: A Pilot Effectiveness Study 09/01/2024 - 12:00am CDT to 09/30/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: October: Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL 10/01/2024 - 12:00am CDT to 10/31/2024 - 11:45pm CDT

Pages